PMP22 and Charcot-Marie-Tooth disease type 1A: The TATA box in the promoter region of overexpressed PMP22 was targeted by CRISPR/Cas9 to knock down its expression level to cure the disease Charcot-Marie-Tooth 1A (CMT1A) in mice model (Lee et al., 2020).